• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 17, Issue 36, 06 September 2012

Rapid communications

Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany


A Hamprecht ()<SUP>1</SUP>, D Buchheidt<SUP>2</SUP>, J J Vehreschild<SUP>3</SUP>, O A Cornely<SUP>3</SUP><SUP>,4</SUP>, B Spiess<SUP>2</SUP>, G Plum<SUP>1</SUP>, T V Halbsguth<SUP>3</SUP>, N Kutsch<SUP>3</SUP>, D Stippel<SUP>5</SUP>, P Kahl<SUP>6</SUP>, T Persigehl<SUP>7</SUP>, A Steinbach<SUP>3</SUP>, B Bos<SUP>3</SUP>, M Hallek<SUP>3</SUP>, M J Vehreschild<SUP>3</SUP>
  1. Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany
  2. Third Department of Internal Medicine, Haematology and Oncology, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany
  3. First Department of Internal Medicine, University of Cologne, Cologne, Germany
  4. Clinical Trials Centre Cologne, ZKS K?ln (BMBF 01KN1106), University of Cologne, Cologne, Germany
  5. Department of General, Visceral and Cancer Surgery, University of Cologne, Germany
  6. Institute of Pathology, University Hospital Cologne, Cologne, Germany
  7. Department of Radiology, University Hospital Cologne, Cologne Germany
<HR>
Citation style for this article: Hamprecht A, Buchheidt D, Vehreschild JJ, Cornely OA, Spiess B, Plum G, Halbsguth TV, Kutsch N, Stippel D, Kahl P, Persigehl T, Steinbach A, Bos B, Hallek M, Vehreschild MJ. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany . Euro Surveill. 2012;17(36):pii=20262. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20262
Date of submission: 16 August 2012
<HR>We report the first culture-proven case of invasive aspergillosis (IA) caused by azole-resistant Aspergillus fumigatus in a patient with acute myeloid leukaemia in Germany. IA presented as breakthrough infection under posaconazole prophylaxis. Analysis of the resistance mechanism revealed the TR/L98H mutation in the cyp51A gene, which indicates an environmental origin of the strain. This case underscores the need for monitoring azole resistance in Aspergillus spp. and for routine susceptibility testing of moulds.
- -------
 
Back
Top Bottom